Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06508775
What this trial is testing

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

Who this might be right for
Melanoma Stage IIIB-cell Non Hodgkin LymphomaPediatric ALL+4 more
Miltenyi Biomedicine GmbH 40
Large-scale testing (Phase 3)Ended earlyNCT06587451
What this trial is testing

Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®

Who this might be right for
Melanoma
Sandoz 52
Testing effectiveness (Phase 2)Study completedNCT01378975
What this trial is testing

Vemurafenib in Metastatic Melanoma Participants With Brain Metastases

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 146
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Testing effectiveness (Phase 2)Study completedNCT00563823
What this trial is testing

Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery

Who this might be right for
Melanoma (Skin)
Cambridge University Hospitals NHS Foundation Trust 34
Not applicableUnknownNCT00264056
What this trial is testing

Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases

Who this might be right for
Advanced Metastastic Malignant MelanomaRefractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases
Fachklinik Hornheide an der Universität Münster 26
Not applicableStudy completedNCT00297895
What this trial is testing

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

Who this might be right for
Melanoma
Saint John's Cancer Institute 1,939
Not applicableLooking for participantsNCT04095195
What this trial is testing

Registry of Subjects at Risk of Pancreatic Cancer

Who this might be right for
Familial Pancreatic CancerBRCA1 MutationBRCA2 Mutation+4 more
Associazione Italiana per lo Studio del Pancreas 1,000
Testing effectiveness (Phase 2)Study completedNCT02379195
What this trial is testing

Peginterferon and TIL Therapy for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Inge Marie Svane 12
Early research (Phase 1)Study completedNCT02858869
What this trial is testing

Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaMucosal Melanoma+4 more
Emory University 25
Testing effectiveness (Phase 2)Ended earlyNCT01369875
What this trial is testing

Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 2
Not applicableUnknownNCT04136470
What this trial is testing

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Who this might be right for
Non Small Cell Lung CancerMicrobiomeMetagenome+2 more
Ardigen 130
Testing effectiveness (Phase 2)Ended earlyNCT00671554
What this trial is testing

Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma

Who this might be right for
Melanoma
Prisma Health-Upstate 3
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Not applicableStudy completedNCT02385253
What this trial is testing

Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance

Who this might be right for
MelanomaNeviSkin Moles
Northwestern University 89
Not applicableStudy completedNCT01859845
What this trial is testing

Melanoma Simulation Model With Smartphone Devices: Training Physicians for Early Detection of Melanoma

Who this might be right for
Melanoma
Northwestern University 63
Early research (Phase 1)UnknownNCT03291002
What this trial is testing

Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC

Who this might be right for
Melanoma (Skin)Squamous Cell Carcinoma of the SkinCarcinoma, Squamous Cell of Head and Neck+1 more
CureVac 98
Testing effectiveness (Phase 2)Study completedNCT00001705
What this trial is testing

Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

Who this might be right for
MelanomaNeoplasm Metastasis
National Cancer Institute (NCI) 141
Testing effectiveness (Phase 2)Ended earlyNCT01308294
What this trial is testing

Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients

Who this might be right for
Melanoma
Centre Hospitalier Universitaire Vaudois 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439344
What this trial is testing

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 53
Next Page